Skip to main content

Table 1 Distribution of baseline characteristics according to levels of IL-6 and YKL-40

From: Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study

 

Group 1*

Group 2*

Group 3*

Group 4*

P value

Age (year), median (IQR)

57 (50–64)

64 (58–71)

60 (53–67)

69 (61–76)

< 0.0001

Male, no. (%)

2355 (73.7)

1268 (62.1)

1511 (74.0)

2031 (63.6)

< 0.0001

Body mass index, median (IQR)

24.8 (22.9–26.7)

24.2 (22.4–26.3)

24.7 (22.9–26.8)

24.2 (22.3–26.3)

< 0.0001

Smoking, no. (%)

1534 (48.0)

779 (38.2)

1071 (52.5)

1270 (39.8)

< 0.0001

Medical history, no. (%)

 Ischemic stroke

563 (17.6)

422 (20.7)

422 (20.7)

830 (26.0)

 < 0.0001

 Diabetes

725 (22.7)

460 (22.5)

519 (25.4)

806 (25.2)

0.02

 Hypertension

1893 (59.3)

1318 (64.6)

1279 (62.7)

2096 (65.6)

< 0.0001

 Hypercholesterolemia

284 (8.9)

135 (6.6)

174 (8.5)

276 (8.6)

0.02

 Coronary heart disease

258 (8.1)

189 (9.3)

202 (9.9)

486 (15.2)

< 0.0001

 Atrial fibrillation

97 (3.0)

89 (4.4)

137 (6.7)

430 (13.5)

< 0.0001

Index event, no. (%)

 Ischemic stroke

2896 (90.6)

1872 (91.7)

1934 (94.8)

3051 (95.5)

< 0.0001

 TIA

299 (9.4)

169 (8.3)

107 (5.2)

144 (4.5)

< 0.0001

Baseline NIHSS, median (IQR)

3 (1–5)

3 (1–5)

4 (2–7)

4 (2–7)

< 0.0001

mRS score before the onset of index events ≥ 2, no. (%)

212 (6.6)

161 (7.9)

185 (9.1)

362 (11.3)

< 0.0001

Leukocyte count (× 109/L), median (IQR)

6.7 (5.6–8.0)

6.5 (5.4–8.0)

7.3 (6.1–8.9)

7.2 (5.9–8.8)

< 0.0001

  1. IL-6 interleukin-6, IQR interquartile range, NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin Scale, LDL-C low-density lipoprotein cholesterol
  2. *Patients were classified into 4 groups according to medians of IL-6 (2.6 ng/L) and YKL-40 (65.3 mg/L). Group 1: IL-6 ≤ 2.6 ng/L and YKL-40 ≤ 65.3 mg/L; group2: IL-6 ≤ 2.6 ng/L and YKL-40 > 65.3 mg/L; group 3: IL-6 > 2.6 ng/L and YKL-40 ≤ 65.3 mg/L; group 4: IL-6 > 2.6 ng/L and YKL-40 > 65.3 mg/L